Page last updated: 2024-08-21

quinazolines and sch 51866

quinazolines has been researched along with sch 51866 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, HS; Chatterjee, M; Chintala, M; Chiu, P; Davis, H; Fawzi, A; Lin, CC; Sybertz, EJ; Tulshian, D; Vemulapalli, S; Watkins, RW1

Other Studies

1 other study(ies) available for quinazolines and sch 51866

ArticleYear
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:6

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Arteries; Blood Platelets; Cattle; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Enzyme Inhibitors; Humans; Hypertension; Imidazoles; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Platelet Aggregation Inhibitors; Quinazolines; Rats; Rats, Inbred SHR

1996